Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7738291rdf:typepubmed:Citationlld:pubmed
pubmed-article:7738291lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:7738291lifeskim:mentionsumls-concept:C0020538lld:lifeskim
pubmed-article:7738291lifeskim:mentionsumls-concept:C0007299lld:lifeskim
pubmed-article:7738291lifeskim:mentionsumls-concept:C0040233lld:lifeskim
pubmed-article:7738291lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:7738291lifeskim:mentionsumls-concept:C1522223lld:lifeskim
pubmed-article:7738291pubmed:issue1lld:pubmed
pubmed-article:7738291pubmed:dateCreated1995-6-8lld:pubmed
pubmed-article:7738291pubmed:abstractTextThe aim of the study was to compare 2 beta-blocker eye drops at a low concentration: 0.5% carteolol and 0.1% timolol.lld:pubmed
pubmed-article:7738291pubmed:languagefrelld:pubmed
pubmed-article:7738291pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7738291pubmed:citationSubsetIMlld:pubmed
pubmed-article:7738291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7738291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7738291pubmed:statusMEDLINElld:pubmed
pubmed-article:7738291pubmed:issn0181-5512lld:pubmed
pubmed-article:7738291pubmed:authorpubmed-author:DascotteJ CJClld:pubmed
pubmed-article:7738291pubmed:authorpubmed-author:AllaireCClld:pubmed
pubmed-article:7738291pubmed:authorpubmed-author:GeorgeJ LJLlld:pubmed
pubmed-article:7738291pubmed:authorpubmed-author:LesurePPlld:pubmed
pubmed-article:7738291pubmed:authorpubmed-author:NordmannJ PJPlld:pubmed
pubmed-article:7738291pubmed:authorpubmed-author:RoulandJ FJFlld:pubmed
pubmed-article:7738291pubmed:authorpubmed-author:SirbatDDlld:pubmed
pubmed-article:7738291pubmed:authorpubmed-author:KhaitrineLLlld:pubmed
pubmed-article:7738291pubmed:authorpubmed-author:TrinquandCClld:pubmed
pubmed-article:7738291pubmed:issnTypePrintlld:pubmed
pubmed-article:7738291pubmed:volume18lld:pubmed
pubmed-article:7738291pubmed:ownerNLMlld:pubmed
pubmed-article:7738291pubmed:authorsCompleteYlld:pubmed
pubmed-article:7738291pubmed:pagination22-6lld:pubmed
pubmed-article:7738291pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7738291pubmed:meshHeadingpubmed-meshheading:7738291-...lld:pubmed
pubmed-article:7738291pubmed:meshHeadingpubmed-meshheading:7738291-...lld:pubmed
pubmed-article:7738291pubmed:meshHeadingpubmed-meshheading:7738291-...lld:pubmed
pubmed-article:7738291pubmed:meshHeadingpubmed-meshheading:7738291-...lld:pubmed
pubmed-article:7738291pubmed:meshHeadingpubmed-meshheading:7738291-...lld:pubmed
pubmed-article:7738291pubmed:meshHeadingpubmed-meshheading:7738291-...lld:pubmed
pubmed-article:7738291pubmed:meshHeadingpubmed-meshheading:7738291-...lld:pubmed
pubmed-article:7738291pubmed:meshHeadingpubmed-meshheading:7738291-...lld:pubmed
pubmed-article:7738291pubmed:meshHeadingpubmed-meshheading:7738291-...lld:pubmed
pubmed-article:7738291pubmed:year1995lld:pubmed
pubmed-article:7738291pubmed:articleTitle[Hypotensive action of 0.5% carteolol versus 0.1% timolol in patients with intraocular hypertension].lld:pubmed
pubmed-article:7738291pubmed:affiliationLaboratoire Chauvin, Montpellier.lld:pubmed
pubmed-article:7738291pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7738291pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:7738291pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7738291pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:7738291pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:7738291pubmed:publicationTypeMulticenter Studylld:pubmed